Position in ANNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,592,315
-$608,290 QoQ
Shares Held
629,127
-17.0% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 216 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. ANNX ranks #29 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in ANNX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,592,315 | 629,127 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,200,605 | 758,232 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,323,449 | 861,245 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,623,707 | 532,363 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,126,101 | 469,209 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $393,700 | 203,990 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $798,458 | 155,645 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $5,594,376 | 944,996 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,469,539 | 912,151 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $6,868,809 | 957,993 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,968,068 | 874,024 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,916,848 | 812,224 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,888,392 | 820,566 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $3,100,324 | 805,279 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $2,051,518 | 396,812 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,491,757 | 403,197 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,510,035 | 400,540 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $390,097 | 142,893 | Shares | Defined | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||